Leonardo Tamariz1, Thomas Harkins, Vinit Nair. 1. Department of Medicine, Miller School of Medicine at the University of Miami, Miami, FL 33136, USA. ltamariz@med.miami.edu
Abstract
BACKGROUND: Drug-induced pro-arrhythmia is a serious and unexpected event. Large administrative and claims databases can potentially identify drugs or interactions leading to cardiac arrhythmias. The purpose of this study is to evaluate the evidence supporting the validity of algorithms or codes to identify ventricular arrhythmias using administrative and claims data. METHODS: A search of MEDLINE database is supplemented by manual searches of bibliographies of key relevant articles. We selected all studies in which an administrative and claims data algorithm or code was validated against a medical record. We report the positive predictive value (PPV) for ICD-9 codes compared to medical records. RESULTS: Our search strategy yielded 664 studies, of which only seven met our eligibility criteria. Two additional studies were identified by peer reviewers. The most commonly included databases were Medicare and Medicaid, and the most commonly evaluated ICD-9 codes were 426.x and 427.x. The individual use of ICD-9 codes 427.x yielded a high PPV (78%-100%). The highest PPV was seen when both ICD-9 codes 427.x and 798.x were used (92%). The same codes yielded the highest PPV when found in the principal diagnosis position (100%). CONCLUSIONS: The use of ICD-9 codes 427.x, alone or in combination with code 798.x, in the principal position is appropriate for the identification of ventricular arrhythmias in administrative and claims databases.
BACKGROUND: Drug-induced pro-arrhythmia is a serious and unexpected event. Large administrative and claims databases can potentially identify drugs or interactions leading to cardiac arrhythmias. The purpose of this study is to evaluate the evidence supporting the validity of algorithms or codes to identify ventricular arrhythmias using administrative and claims data. METHODS: A search of MEDLINE database is supplemented by manual searches of bibliographies of key relevant articles. We selected all studies in which an administrative and claims data algorithm or code was validated against a medical record. We report the positive predictive value (PPV) for ICD-9 codes compared to medical records. RESULTS: Our search strategy yielded 664 studies, of which only seven met our eligibility criteria. Two additional studies were identified by peer reviewers. The most commonly included databases were Medicare and Medicaid, and the most commonly evaluated ICD-9 codes were 426.x and 427.x. The individual use of ICD-9 codes 427.x yielded a high PPV (78%-100%). The highest PPV was seen when both ICD-9 codes 427.x and 798.x were used (92%). The same codes yielded the highest PPV when found in the principal diagnosis position (100%). CONCLUSIONS: The use of ICD-9 codes 427.x, alone or in combination with code 798.x, in the principal position is appropriate for the identification of ventricular arrhythmias in administrative and claims databases.
Authors: Sharan K Rai; J Antonio Aviña-Zubieta; Natalie McCormick; Mary A De Vera; Kam Shojania; Eric C Sayre; Hyon K Choi Journal: Semin Arthritis Rheum Date: 2016-08-17 Impact factor: 5.532
Authors: Mai H Trac; Eric McArthur; Racquel Jandoc; Stephanie N Dixon; Danielle M Nash; Daniel G Hackam; Amit X Garg Journal: CMAJ Date: 2016-02-22 Impact factor: 8.262
Authors: Amr Salama; Abdullah Abdullah; Abdul Wahab; George Eigbire; Ryan Hoefen; Richard Alweis Journal: Cardiol J Date: 2018-09-20 Impact factor: 2.737
Authors: Andreas D Meid; Anna von Medem; Dirk Heider; Jürgen-Bernhard Adler; Christian Günster; Hanna M Seidling; Renate Quinzler; Hans-Helmut König; Walter E Haefeli Journal: Drug Saf Date: 2017-02 Impact factor: 5.606
Authors: Sonal Singh; Hassan Fouayzi; Kathryn Anzuoni; Leah Goldman; Jea Young Min; Marie Griffin; Carlos G Grijalva; James A Morrow; Christine C Whitmore; Charles E Leonard; Mano Selvan; Vinit Nair; Yunping Zhou; Sengwee Toh; Andrew Petrone; James Williams; Elnara Fazio-Eynullayeva; Richard Swain; D Tyler Coyle; Susan Andrade Journal: Drug Saf Date: 2019-04 Impact factor: 5.606
Authors: A Biffi; F Rea; L Scotti; A Mugelli; E Lucenteforte; A Bettiol; A Chinellato; G Onder; C Vitale; N Agabiti; G Trifirò; G Roberto; G Corrao Journal: Eur J Clin Pharmacol Date: 2017-10-18 Impact factor: 2.953
Authors: Aiham Albaeni; May A Beydoun; Hind A Beydoun; Bolanle Akinyele; Lekshminarayan RaghavaKurup; Nisha Chandra-Strobos; Shaker M Eid Journal: Am J Cardiol Date: 2017-05-11 Impact factor: 2.778